Wanda Health is a remote monitoring healthcare analytics and management company for primary care patients with chronic diseases based in San Francisco.

Wanda’s ambition is to significantly control and reduce hospitalisation rates through a Remote Monitoring System (RMS) that collects data from patients’ home to clinicians highlighting the high risks and allowing the action to prevent them. This life personalised medicine combined with secure computing and revolutionary data-mining and analytics improves the quality of life for people with chronic conditions, initially focused on congestive heart failure (CHF).

Chronic disease in the US is accounted for 80% of the total health care bill representing a US$1.4 trillion expenditure. This could be significantly decreased through a severe chronic disease management and appropriate clinical measures.


Investing in start-ups and early-stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution.
It should be done only as part of a diversified portfolio. Any investments are targeted exclusively at investors who understand the risks of investing in early-stage businesses and can make their own investment decisions. Any pitches for investment are not offers to the public.

Investments made in investee companies via funds managed by Sapphire Capital Partners LLP are not covered by the Financial Services Compensation Scheme (FSCS). For more details, please contact us or refer to their website: https://www.fscs.org.uk